Michael Berk

H3K9 methylation drives resistance to androgen receptor–antagonist therapy in prostate cancer

Mehdi Baratchian, Ritika Tiwari, Sirvan Khalighi et al. · Proceedings of the National Academy of Sciences · 2022 · 45 citations · Full text

Urology, Oncology, Receptor–antagonist Therapy +15

Cancer-associated fibroblast-secreted glucosamine alters the androgen biosynthesis program in prostate cancer via HSD3B1 upregulation

Di Cui, Jianneng Li, Ziqi Zhu et al. · Journal of Clinical Investigation · 2023 · 43 citations · Full text

Multiplex Fluorescent Imaging, Oncogenic Agent, Medicine +15

Hexose-6-phosphate dehydrogenase blockade reverses prostate cancer drug resistance in xenograft models by glucocorticoid inactivation

Jianneng Li, Michael Berk, Mohammad Alyamani et al. · Science Translational Medicine · 2021 · 26 citations · Full text

BMX controls 3βHSD1 and sex steroid biosynthesis in cancer

Xiuxiu Li, Michael Berk, Christopher M. Goins et al. · Journal of Clinical Investigation · 2023 · 23 citations · Full text

Androgen Receptor, Biochemistry, Medicine +14

Hypoxia-Reoxygenation Couples 3βHSD1 Enzyme and Cofactor Upregulation to Facilitate Androgen Biosynthesis and Hormone Therapy Resistance in Prostate Cancer

Liang Qin, Yoon‐Mi Chung, Michael Berk et al. · Cancer Research · 2022 · 10 citations · Full text